Top Analyst Upgrades and Downgrades: Altice, CenturyLink, Cigna, Disney, Emerson, Foot Locker, Groupon, Lululemon, Nike, State Street and More

Masonite International Corp. (NYSE: DOOR) closed up 0.8% at $63.02 after earnings. RBC Capital Markets downgraded it to Sector Perform from Outperform, but Stifel boosted its rating to Buy from Hold and raised its target to $80 from $50.

Mosaic Co. (NYSE: MOS) was downgraded to Neutral from Overweight and its target price was lowered to $20 from $24 at JPMorgan. Shares closed up 1.4% at $21.65 ahead of the call but were indicated down 0.8% at $21.48 before the opening bell on Wednesday. The consensus target price was $26.99, and the 52-week trading range is $17.37 to $37.37.

Nike Inc. (NYSE: NKE) was started with an Outperform rating, and the apparel and sporting goods giant was assigned a $100 price target, at Raymond James.

NVR Inc. (NYSE: NVR) was raised to Buy from Neutral at Merrill Lynch.

Prudential Financial Inc. (NYSE: PRU) was downgraded to Market Perform from Outperform by Keefe Bruyette & Woods.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was reiterated as Neutral at Credit Suisse, but the firm raised its target price to $340 from $310. Shares closed up almost 7% at $332.60 on Tuesday, and the prior consensus target price was $379.80.

State Street Corp. (NYSE: STT) was raised to Buy from Hold and the target price was raised to $81 from $64 at Deutsche Bank. The stock closed up 1.6% at $53.66, and its shares have recovered from a 52-week low of $40.78 as the yield curve has become closer to normal. The consensus target price was $52.67.

Tenet Healthcare Corp. (NYSE: THC) was reiterated as Buy and its target price was raised to $33 from $30 (versus a $28.11 close) at Mizuho.

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) was reiterated as Outperform with a $70 target price (versus a $39.86 close) at Wedbush Securities. The firm sees its focus tilting toward gene therapy for now and continues to see its pipeline as largely not represented in current estimates and also where the risk/reward skewed to the upside.

Vishay Intertechnology Inc. (NYSE: VSH) was downgraded to Underperform from Neutral with a $17 price objective (versus a $20.72 close) at Merrill Lynch.

Walt Disney Co. (NYSE: DIS) was maintained as Buy at UBS, but the firm trimmed its price target to $155 from $165.

Zimmer Biomet Holdings Inc. (NYSE: ZBH) was reiterated as Buy and the price target was raised to $165 from $158 at UBS. RBC Capital Markets reiterated its Outperform rating and raised its target to $165 from $155. The stock closed up 2.77% at $140.31, and its prior consensus target price was $151.64.

The analysts at Jefferies have four top growth stock picks for this week that are members of the firm’s Franchise Picks list, and these technology leaders all have solid upside to the firm’s price targets.

Wedbush has issued a report on overall technology stocks and the U.S./China trade war, noting that as the trade battle appears to be heading toward an important Phase 1 agreement over the next month and an eventual broader deal further down the line, this ultimately will remove the biggest risk for tech names heading into year-end and 2020. It specifically sees a win for Apple Inc. (NASDAQ: AAPL) if the tariffs are not put on, and it sees the semiconductor space as the poster child of the beneficiaries if there is a Phase I resolution.

Tuesday’s top analyst upgrades and downgrades included Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber, Under Armour, U.S. Steel and many more.